Evidence map›Paper›PMID 42552389›Full record

ArticleNature2026

Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Toni K Choueiri, Jaime Merchán, Amita Patnaik, Alexandra Drakaki, Brian I Rini, Sun Young Rha, Jae Lyun Lee, Moshe C Ornstein, Rohit Kumar, Clara Hwang and 16 more

Abstract readPublished Erratum
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Toni K ChoueiriDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-9201-3217
Jaime MerchánUniversity of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Amita PatnaikThe START Center for Cancer Research, San Antonio, TX, USA.
Alexandra DrakakiDivision of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8865-3548
Brian I RiniVanderbilt-Ingram Cancer Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-2212-080X
Sun Young RhaYonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0002-2512-4531
Jae Lyun LeeAsan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Moshe C OrnsteinDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Rohit KumarDivision of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Clara HwangDepartment of Internal Medicine, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA.
Yusra ShaoKarmanos Cancer Center, Detroit, MI, USA.
Se Hoon ParkDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pedro C BarataUniversity Hospitals Seidman Cancer Center, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8890-2951
Bradley A McGregorDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8298-0289
Paul FosterArcus Biosciences, Inc., Hayward, CA, USA.ORCID http://orcid.org/0009-0008-3268-5426
Jianfen ChenArcus Biosciences, Inc., Hayward, CA, USA.
Melissa EisenArcus Biosciences, Inc., Hayward, CA, USA.
Hunter ColeArcus Biosciences, Inc., Hayward, CA, USA.
Ben WeederArcus Biosciences, Inc., Hayward, CA, USA.
Yinghui GuanArcus Biosciences, Inc., Hayward, CA, USA.
Jaskirat SinghArcus Biosciences, Inc., Hayward, CA, USA.
Angelo KaplanArcus Biosciences, Inc., Hayward, CA, USA.ORCID http://orcid.org/0009-0005-3231-6055
Soonweng ChoArcus Biosciences, Inc., Hayward, CA, USA.
Richard MarkusArcus Biosciences, Inc., Hayward, CA, USA.
Omar KabbarahArcus Biosciences, Inc., Hayward, CA, USA.
Rana R McKayDivision of Hematology Oncology, University of California, San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-0581-7963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42552389
PMCPMC13489946

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.